Table 3.

Correlation analysis between percentage FMD change and the main characteristics of the population

	FMD
	LVAD		HT		HF
	rho	P	rho	P	rho	P
Age	0.15	0.45	−0.07	0.6	−0.1	0.4
Male gender	0.15	0.46	−0.2	0.13	−0.05	0.7
Smoke	0.03	0.7	0.04	0.8	−0.2	0.2
BMI	0.2	0.26	−0.3	0.014	−0.2	0.16
Heart rate	−0.2	0.26	0.02	0.84	0.2	0.1
Mean arterial pressure	−0.11	0.57
SBP			−0.2	0.09	−0.05	0.7
DBP			−0.19	0.16	−0.05	0.7
NT‐pro BNP	−0.2	0.3	0.1	0.42	0.1	0.4
CRP	−0.4	0.02	−0.2	0.1	−0.02	0.8
LVEF (%)	0.01	0.9	0.09	0.5	0.18	0.3
NYHA class	0.2	0.27	−0.01	0.39	−0.1	0.6
Hypercholesterolaemia	0.2	0.18	0.05	0.7	0.03	0.8
Hypertension	0.2	0.2	−0.1	0.3	−0.1	0.47
Diabetes N (%)	−0.09	0.6	−0.2	0.2	−0.1	0.46
Obesity (%)	0.07	0.69	0.01	0.9	−0.2	0.1
Ischaemic aetiology	0.25	0.18	−0.2	0.06	0.002	0.9

Abbreviations: BMI, body mass index; CRP, C‐reactive protein; DBP, diastolic blood pressure; FMD, flow‐mediated dilation; HF, heart failure; HT, heart transplantation; LVAD, left ventricular assist device; LVEF, left ventricle ejection fraction; NYHA, New York Heart Association; SBP, systolic blood pressure.

Statistical significance was considered for P < 0.05.